Dudley & Shanley Inc. Has $30.65 Million Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Dudley & Shanley Inc. lessened its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 0.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 461,621 shares of the company’s stock after selling 1,050 shares during the period. Ryan Specialty accounts for about 4.8% of Dudley & Shanley Inc.’s portfolio, making the stock its 4th largest position. Dudley & Shanley Inc. owned 0.18% of Ryan Specialty worth $30,647,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Signaturefd LLC increased its stake in shares of Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after buying an additional 148 shares during the period. UMB Bank n.a. boosted its holdings in Ryan Specialty by 5.2% in the third quarter. UMB Bank n.a. now owns 5,224 shares of the company’s stock valued at $347,000 after acquiring an additional 256 shares during the last quarter. Loomis Sayles & Co. L P increased its position in Ryan Specialty by 26.3% in the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after purchasing an additional 286 shares during the period. Hollencrest Capital Management bought a new stake in Ryan Specialty during the 3rd quarter worth about $25,000. Finally, Quarry LP lifted its position in Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after purchasing an additional 422 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Bank of America lifted their price objective on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research note on Thursday, October 10th. Morgan Stanley started coverage on Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target on the stock. Barclays increased their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Wells Fargo & Company lifted their price target on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Finally, BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $65.00 to $75.00 in a report on Tuesday, September 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $73.50.

Insider Activity at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00. Following the transaction, the director now owns 50,400 shares in the company, valued at $3,284,568. The trade was a 40.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director David P. Bolger sold 7,055 shares of the stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 126,936 shares of company stock worth $8,536,282 in the last quarter. 11.10% of the stock is owned by insiders.

Ryan Specialty Price Performance

RYAN stock traded down $0.12 during mid-day trading on Monday, hitting $63.89. The stock had a trading volume of 677,736 shares, compared to its average volume of 877,499. The firm has a fifty day simple moving average of $70.23 and a 200 day simple moving average of $64.86. Ryan Specialty Holdings, Inc. has a 52 week low of $41.65 and a 52 week high of $75.97. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market capitalization of $16.73 billion, a P/E ratio of 82.97, a P/E/G ratio of 1.52 and a beta of 0.67.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts’ consensus estimates of $0.41. The firm had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.32 earnings per share. As a group, research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.

Ryan Specialty Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were issued a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is currently 57.14%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.